Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23611711 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
Conditions: Thromboangiitis Obliterans;   Arteritis;   Peripheral Arterial Disease
Interventions: Other: autologous purified CD34+ cells;   Other: autologous peripheral blood mononuclear cells

Indicates status has not been verified in more than two years